Tim Nye



Tim is Head of Corporate at Trowers & Hamlins and advises on all aspects of private equity including real estate private equity and investment, buy outs, seed investment transactions, divestments and disposals and management incentive packages.

He works with investee companies whilst under private equity ownership advising on, amongst other things, group restructurings, refinancings, strategic sales, bolt on acquisitions and organic growth.

Tim also developed the model "Outsourcing the Company Secretary" by which investee companies take advantage of Trowers & Hamlins' full suite of legal services for ad hoc and day to day matters, allowing the firm to track trends within the organisation and build up a corporate history on behalf of the company and its investors.

In 2020, The Lawyer included Tim in it's annual Hot 100 list of the most daring, innovative and creative lawyers. He is also recognised as a global leader in the Who's Who Legal guide for healthcare 2021 as well as a Notable Practitioner for healthcare (UK-wide) in Chambers & Partners 2019.

"He is accessible, commercial and practical in his advice."

Chambers UK 2021

"Tim Nye has great knowledge of real estate and able to think across to different subsectors to help frame structures. Very deal-focused and maintains both momentum and detail in progressing complex issues.""Tim Nye is excellent. He provides calm clear advice and is always available to ensure the right teams are in place."

Legal 500 2020
News

Trowers & Hamlins continues growth into mid-market Private Equity space with key double partner hire

Explore
News

Trowers advises on £66.5m financing for development of Surrey luxury retirement development

Explore
News

UK mid-market M&A: A challenging 2023 sees activity subdued, but reasons for optimism in '24

Explore
Insight

Report: Monitoring mid-market M&A in the UK - 2024

Explore
News

Two lateral hires further strengthen Trowers' Tax and Commercial practices

Explore
News

Trowers advises SLIP and Audley Group on UK retirement living joint venture

Explore